• 7666 Citations
  • 41 h-Index
1987 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert H Collins is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 7666 Citations
  • 41 h-Index
  • 103 Article
  • 1 Letter

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

Zhang, H., Savage, S., Schultz, A. R., Bottomly, D., White, L., Segerdell, E., Wilmot, B., McWeeney, S. K., Eide, C. A., Nechiporuk, T., Carlos, A., Henson, R., Lin, C., Searles, R., Ho, H., Lam, Y. L., Sweat, R., Follit, C., Jain, V., Lind, E. & 10 others, Borthakur, G., Garcia-Manero, G., Ravandi, F., Kantarjian, H. M., Cortes, J., Collins, R. H., Buelow, D. R., Baker, S. D., Druker, B. J. & Tyner, J. W., Dec 1 2019, In : Nature communications. 10, 1, 244.

Research output: Contribution to journalArticle

Open Access
  • 15 Scopus citations

    Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

    Pollyea, D. A., Tallman, M. S., de Botton, S., Kantarjian, H. M., Collins, R. H., Stein, A. S., Frattini, M. G., Xu, Q., Tosolini, A., See, W. L., MacBeth, K. J., Agresta, S. V., Attar, E. C., DiNardo, C. D. & Stein, E. M., Jan 1 2019, In : Leukemia.

    Research output: Contribution to journalArticle

    Open Access
  • 9 Scopus citations

    Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

    Zhang, H., Wilmot, B., Bottomly, D., Dao, K. H. T., Stevens, E., Eide, C. A., Khanna, V., Rofelty, A., Savage, S., Schultz, A. R., Long, N., White, L., Carlos, A., Henson, R., Lin, C., Searles, R., Collins, R. H., DeAngelo, D. J., Deininger, M. W., Dunn, T. & 12 others, Hein, T., Luskin, M. R., Medeiros, B. C., Oh, S. T., Pollyea, D. A., Steensma, D. P., Stone, R. M., Druker, B. J., McWeeney, S. K., Maxson, J. E., Gotlib, J. R. & Tyner, J. W., Sep 12 2019, In : Blood. 134, 11, p. 867-879 13 p.

    Research output: Contribution to journalArticle

  • 6 Scopus citations

    Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib

    Stein, E. M., DiNardo, C. D., Fathi, A. T., Pollyea, D. A., Stone, R. M., Altman, J. K., Roboz, G. J., Patel, M. R., Collins, R. H., Flinn, I. W., Sekeres, M. A., Stein, A. S., Kantarjian, H. M., Levine, R. L., Vyas, P., MacBeth, K. J., Tosolini, A., VanOostendorp, J., Xu, Q., Gupta, I. & 7 others, Lila, T., Risueno, A., Yen, K. E., Wu, B., Attar, E. C., Tallman, M. S. & de Botton, S., Feb 14 2019, In : Blood. 133, 7, p. 676-687 12 p.

    Research output: Contribution to journalArticle

  • 33 Scopus citations

    Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML

    DiNardo, C. D., Stein, E. M., De Botton, S., Roboz, G. J., Altman, J. K., Mims, A. S., Swords, R., Collins, R. H., Mannis, G. N., Pollyea, D. A., Donnellan, W., Fathi, A. T., Pigneux, A., Erba, H. P., Prince, G. T., Stein, A. S., Uy, G. L., Foran, J. M., Traer, E., Stuart, R. K. & 20 others, Arellano, M. L., Slack, J. L., Sekeres, M. A., Willekens, C., Choe, S., Wang, H., Zhang, V., Yen, K. E., Kapsalis, S. M., Yang, H., Dai, D., Fan, B., Goldwasser, M., Liu, H., Agresta, S., Wu, B., Attar, E. C., Tallman, M. S., Stone, R. M. & Kantarjian, H. M., Jun 21 2018, In : New England Journal of Medicine. 378, 25, p. 2386-2398 13 p.

    Research output: Contribution to journalArticle

  • 203 Scopus citations